Anne Fabienne Weitsch
Plus aucun poste en cours
Profil
Anne Fabienne Weitsch served as Chief Executive Officer at Endocells SARL and as Principal at Johnson & Johnson and Zyman Group LLC.
She was also a Member at J&J, Inc. and The Janssen Research Foundation.
Weitsch was Vice President-Business Development at H-Phar NV from 2007 to 2011 and Vice President-Business Development at Signature Diagnostics AG.
She holds a doctorate degree from the University of Cambridge and the University of Geneva.
Anciens postes connus de Anne Fabienne Weitsch
| Sociétés | Poste | Fin |
|---|---|---|
H-Phar NV
 H-Phar NV Pharmaceuticals: MajorHealth Technology H-PHAR SA was founded in 2002 to develop products based on Hubriphar SA 'Know How', in particular, a drug (Azodicarbonamide) inactivating the retroviral nucleocapside Protein 7 (NCp7) opening a new therapeutic route to treat mutated HIV resistant to the actual therapy combining at least three active medicinal products. H-Phar is a pharmaceutical research company that develops candidate drugs based on its own worldwide patented technology. Through, knowledge, creativity and integrity, H-Phar aims to preserve and improve human health by offering treatments to everyone everywhere. H-Phar is active in four operating areas include preclinical research focusing on the development of anti-viral applications of the so-called 'zinc finger ejector' in the domain of hemorrhagic fever (arenaviruses) and oncoviruses (HPV**), preclinical research focusing on the development of immune-modulator drugs inhibiting graft rejection, clinical development of an anti-HIV*drug based on a totally new mechanism of action, Vaccine evaluation of a dendritic cell loaded with HPH116 killed virus vaccine for immunological responses boost. H-Phar studies are compliant with OCDE Guidelines and ICH/GMP/GLP/GCP rules. H-Phar has build partnerships with opinion leaders in major institutions in Belgium, Europe and the US. | Corporate Officer/Principal | 10/01/2011 |
Endocells SARL
 Endocells SARL BiotechnologyHealth Technology Endocells SARL develops a technology platform for the generation and development of human endocrine cell lines. The firm also engages in cell engineering. The company was founded by Raphaël Scharfmann, Paul Czernichowon and Philippe Ravassard on August 30, 2004 and is headquartered in Paris, France. | Directeur Général | - |
Signature Diagnostics AG
 Signature Diagnostics AG Pharmaceuticals: MajorHealth Technology Signature Diagnostics AG operates as a molecular diagnostics company. It discovers, validates and develops novel diagnostic products that predict outcome and drug response in patients with colorectal cancer, non-small cell lung cancer and ovarian cancer. The company was founded by André Rosenthal in 2004 and is headquartered in Potsdam, Germany. | Corporate Officer/Principal | - |
Zyman Group LLC
 Zyman Group LLC Miscellaneous Commercial ServicesCommercial Services Zyman Group LLC provides management consulting services. The firm provides advice and assistance to other companies in areas such as strategy, marketing, sales, organizational structure, business, technical, and human resources issues. The company was founded by Timothy R. Pearson and Sergio Zyman in 1999 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
J&J, Inc.
 J&J, Inc. Industrial MachineryProducer Manufacturing Part of The Home Depot, Inc., J&J, Inc. provides nickel and nickel alloy pipe and pipe fittings. The company is based in Atlanta, GA. J & J, Inc. was acquired by Hughes Supply, Inc. on November 01, 1996. | Corporate Officer/Principal | - |
Formation de Anne Fabienne Weitsch
| University of Cambridge | Doctorate Degree |
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 6 |
|---|---|
Zyman Group LLC
Zyman Group LLC Miscellaneous Commercial ServicesCommercial Services Zyman Group LLC provides management consulting services. The firm provides advice and assistance to other companies in areas such as strategy, marketing, sales, organizational structure, business, technical, and human resources issues. The company was founded by Timothy R. Pearson and Sergio Zyman in 1999 and is headquartered in Madison, NJ. | Commercial Services |
J&J, Inc.
J&J, Inc. Industrial MachineryProducer Manufacturing Part of The Home Depot, Inc., J&J, Inc. provides nickel and nickel alloy pipe and pipe fittings. The company is based in Atlanta, GA. J & J, Inc. was acquired by Hughes Supply, Inc. on November 01, 1996. | Producer Manufacturing |
H-Phar NV
H-Phar NV Pharmaceuticals: MajorHealth Technology H-PHAR SA was founded in 2002 to develop products based on Hubriphar SA 'Know How', in particular, a drug (Azodicarbonamide) inactivating the retroviral nucleocapside Protein 7 (NCp7) opening a new therapeutic route to treat mutated HIV resistant to the actual therapy combining at least three active medicinal products. H-Phar is a pharmaceutical research company that develops candidate drugs based on its own worldwide patented technology. Through, knowledge, creativity and integrity, H-Phar aims to preserve and improve human health by offering treatments to everyone everywhere. H-Phar is active in four operating areas include preclinical research focusing on the development of anti-viral applications of the so-called 'zinc finger ejector' in the domain of hemorrhagic fever (arenaviruses) and oncoviruses (HPV**), preclinical research focusing on the development of immune-modulator drugs inhibiting graft rejection, clinical development of an anti-HIV*drug based on a totally new mechanism of action, Vaccine evaluation of a dendritic cell loaded with HPH116 killed virus vaccine for immunological responses boost. H-Phar studies are compliant with OCDE Guidelines and ICH/GMP/GLP/GCP rules. H-Phar has build partnerships with opinion leaders in major institutions in Belgium, Europe and the US. | Health Technology |
| The Janssen Research Foundation | |
Signature Diagnostics AG
Signature Diagnostics AG Pharmaceuticals: MajorHealth Technology Signature Diagnostics AG operates as a molecular diagnostics company. It discovers, validates and develops novel diagnostic products that predict outcome and drug response in patients with colorectal cancer, non-small cell lung cancer and ovarian cancer. The company was founded by André Rosenthal in 2004 and is headquartered in Potsdam, Germany. | Health Technology |
Endocells SARL
Endocells SARL BiotechnologyHealth Technology Endocells SARL develops a technology platform for the generation and development of human endocrine cell lines. The firm also engages in cell engineering. The company was founded by Raphaël Scharfmann, Paul Czernichowon and Philippe Ravassard on August 30, 2004 and is headquartered in Paris, France. | Health Technology |
